Share the post "New app To Help Doctors Predict Preterm Birth Risk"
Scientists have invented a new app that uses an algorithm to help doctors to better identify women at risk of giving birth prematurely.
The app nicknamed Quipp, developed by researchers at King’s College London, was tested in two studies of high-risk women being monitored at ante-natal clinics.
How it works?
The app uses an algorithm which combines the gestation of previous pregnancies and the length of the cervix with levels of foetal fibronectin to classify a woman’s risk.
The first study focused on women deemed to be at high risk of preterm birth, usually because of a previous early pregnancy, despite not showing any symptoms.
The second study predicted the likelihood of early delivery in a group of women showing symptoms of early labour which often does not progress to real labour.
In the first study, researchers collected data from 1,249 women at high risk for pre-term birth attending pre-term surveillance clinics. The model was developed on the first 624 consecutive women and validated on the subsequent 625.
Researchers found that the estimated probability of delivery before 30, 34 or 37 weeks’ gestation and within two or four weeks of testing for foetal fibronectin was calculated for each patient and analyzed as a predictive test for the actual occurrence of each event.
In the second study, data from 382 high-risk women was collected. The model was developed on the first 190 women and validated on the remaining 192.
In both studies, the app was found to perform well as a predictive tool, and far better than each component (previous pregnancy, cervical length or foetal fibronectin) taken alone.
It is to be noted that worldwide 15 million babies are born preterm (before 37 weeks) each year and over a million of these die of prematurity-related complications.
A number of factors are used to determine if a woman is at risk of giving birth prematurely, including a history of preterm births or late miscarriages.
Two further factors which doctors can consider are the length of cervix and levels of a biomarker found in vaginal fluid known as foetal fibronectin, which are typically tested from 23 weeks. The researchers have further developed the foetal fibronectin test to be accurately used from the first half of pregnancy.